287 related articles for article (PubMed ID: 16764777)
1. [Clinical significance of CD117/CD34 co-expression in adult patients with acute leukemia].
Shi H; Zhu F; Xiao AQ; Zhang ZR; Zhang R
Ai Zheng; 2006 Jun; 25(6):762-4. PubMed ID: 16764777
[TBL] [Abstract][Full Text] [Related]
2. C-kit receptor tyrosine kinase (CD117) expression and its positive predictive value for the diagnosis of Thai adult acute myeloid leukemia.
Auewarakul CU; Lauhakirti D; Promsuwicha O; Munkhetvit C
Ann Hematol; 2006 Feb; 85(2):108-12. PubMed ID: 16320053
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
[TBL] [Abstract][Full Text] [Related]
4. Adult and childhood acute lymphoblastic leukemia: clinico-biological differences based on CD34 antigen expression.
Cascavilla N; Musto P; D'Arena G; Ladogana S; Matera R; Carotenuto M
Haematologica; 1997; 82(1):31-7. PubMed ID: 9107079
[TBL] [Abstract][Full Text] [Related]
5. [MIC categorization of acute lymphoblastic leukemia with myeloid surface antigen expression].
Wu WL; Liang JY; Zhu MQ; Xue YQ; Chen ZX
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):754-6. PubMed ID: 18457267
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of anti-CD117 in the flow cytometric analysis of acute leukemia.
Hans CP; Finn WG; Singleton TP; Schnitzer B; Ross CW
Am J Clin Pathol; 2002 Feb; 117(2):301-5. PubMed ID: 11863227
[TBL] [Abstract][Full Text] [Related]
7. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
[TBL] [Abstract][Full Text] [Related]
8. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
[TBL] [Abstract][Full Text] [Related]
9. Clinical and biological relevance of flow cytometric determination of P-glycoprotein expression in acute non-lymphocytic leukemia.
Li J; Xia X; Hua D; Wang W; Chen Z; Ruan C
Chin Med J (Engl); 1997 Dec; 110(12):919-22. PubMed ID: 9772402
[TBL] [Abstract][Full Text] [Related]
10. Relation of some cytochemical activities to the expression of CD34 marker in acute leukemia.
Klobusická M; Babusíková O; Hrivnáková A
Neoplasma; 1993; 40(5):309-14. PubMed ID: 7505888
[TBL] [Abstract][Full Text] [Related]
11. [Study on the expression of myeloid markers and CD34 antigen in adult acute lymphoblastic leukemia].
Mi Y; Bian S; Chen G
Zhonghua Xue Ye Xue Za Zhi; 1999 Feb; 20(2):76-8. PubMed ID: 11601203
[TBL] [Abstract][Full Text] [Related]
12. CD34/CD117 positivity in assessment of prognosis in children with myelodysplastic syndrome.
Tavil B; Cetin M; Tuncer M
Leuk Res; 2006 Feb; 30(2):222-4. PubMed ID: 16098587
[TBL] [Abstract][Full Text] [Related]
13. CD117 expression is a sensitive but nonspecific predictor of FLT3 mutation in T acute lymphoblastic leukemia and T/myeloid acute leukemia.
Hoehn D; Medeiros LJ; Chen SS; Tian T; Jorgensen JL; Ahmed Y; Lin P
Am J Clin Pathol; 2012 Feb; 137(2):213-9. PubMed ID: 22261446
[TBL] [Abstract][Full Text] [Related]
14. Expression of the hMICL in acute myeloid leukemia-a highly reliable disease marker at diagnosis and during follow-up.
Larsen HØ; Roug AS; Just T; Brown GD; Hokland P
Cytometry B Clin Cytom; 2012 Jan; 82(1):3-8. PubMed ID: 22173921
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
[TBL] [Abstract][Full Text] [Related]
16. Comparison of mRNA abundance quantified by gene expression profiling and percentage of positive cells using immunophenotyping for diagnostic antigens in acute and chronic leukemias.
Kern W; Kohlmann A; Schoch C; Schnittger S; Haferlach T
Cancer; 2006 Nov; 107(10):2401-7. PubMed ID: 17041886
[TBL] [Abstract][Full Text] [Related]
17. CD117/CD34 expression in leukemic blasts.
Wells SJ; Bray RA; Stempora LL; Farhi DC
Am J Clin Pathol; 1996 Aug; 106(2):192-5. PubMed ID: 8712172
[TBL] [Abstract][Full Text] [Related]
18. CD34 expression in native human acute myelogenous leukemia blasts: differences in CD34 membrane molecule expression are associated with different gene expression profiles.
Oyan AM; Bø TH; Jonassen I; Ulvestad E; Gjertsen BT; Kalland KH; Bruserud O
Cytometry B Clin Cytom; 2005 Mar; 64(1):18-27. PubMed ID: 15668952
[TBL] [Abstract][Full Text] [Related]
19. Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia.
Monreal MB; Pardo ML; Pavlovsky MA; Fernandez I; Corrado CS; Giere I; Sapia S; Pavlovsky S
Cytometry B Clin Cytom; 2006 Mar; 70(2):63-70. PubMed ID: 16470534
[TBL] [Abstract][Full Text] [Related]
20. Positive selection for CD90 as a purging option in acute myeloid leukemia stem cell transplants.
Feller N; Kelder A; Westra G; Ossenkoppele GJ; Schuurhuis GJ
Cytometry B Clin Cytom; 2008 Jan; 74(1):9-16. PubMed ID: 18061946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
